Zai Lab Limited (HKG:9688)
Hong Kong · Delayed Price · Currency is HKD 14.48
+0.85 (6.24%)
At close: Dec 24, 2025
Zai Lab Employees
Zai Lab had 1,869 employees as of December 31, 2024. The number of employees decreased by 306 or -14.07% compared to the previous year.
Employees
1,869
Change (1Y)
-306
Growth (1Y)
-14.07%
Revenue / Employee
1.84M HKD
Profits / Employee
-860.96K HKD
Market Cap
16.07B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,869 | -306 | -14.07% |
| Dec 31, 2023 | 2,175 | 139 | 6.83% |
| Dec 31, 2022 | 2,036 | 85 | 4.36% |
| Dec 31, 2021 | 1,951 | 757 | 63.40% |
| Dec 31, 2020 | 1,194 | 502 | 72.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sino Biopharmaceutical | 24,379 |
| CSPC Pharmaceutical Group | 21,400 |
| WuXi Biologics | 12,575 |
| BeOne Medicines AG | 11,000 |
| Hansoh Pharmaceutical Group Company | 8,989 |
| Innovent Biologics | 5,659 |
| JD Health International | 3,564 |
| Akeso | 3,035 |
Zai Lab News
- 1 day ago - Zai Lab Receives Approval In China For Schizophrenia Drug COBENFY - Nasdaq
- 2 days ago - Zai Lab Secures China's Approval For Schizophrenia Therapy In Adults - Nasdaq
- 2 days ago - Zai Lab Announces Approval of COBENFY (xanomeline and trospium chloride) in China, a First-in-Class Therapy for Schizophrenia - Business Wire
- 6 days ago - Insider Sell: Edmondson Frazor Titus III Sells 8,651 Shares of Zai Lab Ltd (ZLAB) - GuruFocus
- 17 days ago - Zai Lab Announces Dosing of First Participant in Global Phase 1/1b study of ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis - Business Wire
- 18 days ago - Zai Lab (ZLAB) Secures Renewal for Key Drugs in China's 2025 NRDL - GuruFocus
- 18 days ago - Zai Lab Announces Updates to China's National Reimbursement Drug List - Business Wire
- 5 weeks ago - Wellington Management Group LLP's Strategic Acquisition in Zai Lab Ltd - GuruFocus